This topic contains a solution. Click here to go to the answer

Author Question: A drug that would treat obesity might be expected to A) promote the activity of uncoupling ... (Read 23 times)

littleanan

  • Hero Member
  • *****
  • Posts: 575
A drug that would treat obesity might be expected to
 
  A) promote the activity of uncoupling protein in skeletal muscle.
  B) suppress metabolic rate.
  C) impair the activity of uncoupling protein in skeletal muscle.
  D) promote the development of a thrifty phenotype.
  E) block the transport of leptin into the brain.

Question 2

A key factor for the success of the RYGB procedure for the treatment of obesity is that
 
  A) the procedure increases the rate of entry of insulin into the brain.
  B) it disrupts the secretion of CCK.
  C) it increases the activity of NPY neurons.
  D) it disrupts the secretion of ghrelin.
  E) it decreases the secretion of leptin from fat cells.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

milbourne11

  • Sr. Member
  • ****
  • Posts: 322
Answer to Question 1

Answer: A
Rationale: A drug that would treat obesity might be expected to promote the activity of uncoupling protein in skeletal muscle.

Answer to Question 2

Answer: D
Rationale: A key factor for the success of the RYGB procedure for the treatment of obesity is that it disrupts the secretion of ghrelin.




littleanan

  • Member
  • Posts: 575
Reply 2 on: Jun 22, 2018
Thanks for the timely response, appreciate it


peter

  • Member
  • Posts: 330
Reply 3 on: Yesterday
Great answer, keep it coming :)

 

Did you know?

The Romans did not use numerals to indicate fractions but instead used words to indicate parts of a whole.

Did you know?

About 3.2 billion people, nearly half the world population, are at risk for malaria. In 2015, there are about 214 million malaria cases and an estimated 438,000 malaria deaths.

Did you know?

GI conditions that will keep you out of the U.S. armed services include ulcers, varices, fistulas, esophagitis, gastritis, congenital abnormalities, inflammatory bowel disease, enteritis, colitis, proctitis, duodenal diverticula, malabsorption syndromes, hepatitis, cirrhosis, cysts, abscesses, pancreatitis, polyps, certain hemorrhoids, splenomegaly, hernias, recent abdominal surgery, GI bypass or stomach stapling, and artificial GI openings.

Did you know?

Despite claims by manufacturers, the supplement known as Ginkgo biloba was shown in a study of more than 3,000 participants to be ineffective in reducing development of dementia and Alzheimer’s disease in older people.

Did you know?

The horizontal fraction bar was introduced by the Arabs.

For a complete list of videos, visit our video library